EKB Journal Management System
1.

Study the value of Fecal Calprotectin in neonate with congenital heart disease and necrotizing enterocollitis

Articles in Press, Accepted Manuscript , Available Online from 15 July 2025
Somaia A Elwan; Abeer E Karish; Maha M Osman; Eman G Abdelrahman
2.

Value of Fecal Galectin-3 in Assessment of Activity and Remission of Ulcerative Colitis

Articles in Press, Accepted Manuscript , Available Online from 16 October 2025
Mohammed E. El- Shewi; Yehia S. Younes; Amira R. Elhawary; Radwa M. Elsharaby; Yousry E. Aboamer
3.

Feeding Intolerance and Faecal Calprotectin in Preterm Neonates on 3 Different Feeding Protocols: A Comparative Study

Volume 28, Issue 4, October 2025
4.

STUDY OF FECAL CALPROTECTIN AS A NON-INVASIVE MARKER ASSOCIATED WITH DISEASE ACTIVITY IN CHRONIC GASTRITIS ADULT PATIENTS

Volume 7, Issue 3, July 2025, Pages 50-51
Salah-Eddin Ahmed Badr-Eddin; Ahmed Ismael Al-Lakany; Eman Nassar; Maha Guimei; Basma Ahmed Mohamed Abdelrahman Saleh
5.

Fecal Calprotectin as Screening Parameter for Hepatic Encephalopathy

Volume 42, Issue 7, July 2025, Pages 816-825
Ahmed Mohammad Abd El Mawla Amin; Magdy Abdel Mawgoud Gad; Ahmed Ahmed Shams Eldin Negm
6.

Role of Fecal and Blood Markers in The Assessment of Severity of Ulcerative Colitis

Volume 42, Issue 1, January 2025, Pages 280-292
Ahmed Mohammad Abd El Mawla; Nada Ahmed Ali Allam; Ashraf Raafat Abouel Fetouh; Osama Elbaz Elagroudy; Mohammad Abd El Hamid Mohammad
7.

Evaluation of fecal calprotectin in patients with juvenile polyps before and after polypectomy

Volume 8, Issue 1, 2025, Pages 74-88
Mohammed Abdel-Hafez Ali; Hossam A. Galbt; Ayman Ahmed Sakr
8.

Effect of Colonoscopy on Fecal Calprotectin Testing

Volume 8, Issue 1, 2025, Pages 89-99
Mohamed Farouk; Helal F Hetta; Amel Ahmed Moustafa; Essam Eldeen M O Mahran; Mohamed Abdelghani; Manal M Darwish; Ebtisam Shawky Ahmed Hassanin; Mohamed Abdel Fatah Mohamed Sayed
9.

Study of cut-off level for Fecal Calprotectin and Its Relation to Endoscopic and Histological Remission in IBD Egyptian Patients

Volume 6, Issue 9, September 2024, Pages 4881-4888
Abdelnaser Gadallah; Abdallah Bahnacy; Alyaa Moselhy; John Hanany; Hany Abdelbary
10.

Fecal Calprotectin as a Marker of Severity of COVID-19 Disease: A Hospital-based Study

Volume 7, Issue 1, 2024, Pages 225-247
Ahmed Ibrahim Gad; Amr EL Hawary; Rania M. Abdullah; Amir Abd-elhameed Barakat
11.

Evaluation of Faecal Calprotectin Level in Psoriatic and Hidradenitis Suppurativa Patients as a Model of an Autoimmune and Auto-Inflammatory Disease Retrospectively

Volume 93, Issue 1, October 2023, Pages 6914-6918
12.

Predictive value of trefoil factor 3 for identifying activity in ulcerative colitis patients: a comparison with fecal calprotectin and C-reactive protein

Volume 4, Issue 2, July 2023, Pages 109-118
Ahmed A. Khairallah; Mohammed S. El-Fayoumy; Ashraf A. El-Sherbiny; Mohammed S. El-shorbagy; Fathy A. El-ghamry
13.

Serum Amyloid A as a Biomarker of Ulcerative Colitis Disease Activity

Volume 40, Annual conference issue, March and April 2023, Pages 87-102
Hany Elkholy; Hossam Ameen Biomy; Enas Sebaey Ahmad; Safaa Esam shehata Elmasry; Yousry Esam-Eldin Abo-Amer
14.

Monitoring of Ulcerative Colitis Disease Activity During Pregnancy Using CRP/Albumin Ratio

Volume 91, Issue 03, March 2023, Pages 437-443
MOHAMED A. EL-NADY, M.D.*; HYAM FATHY, M.D.**
15.

Study of fecal calprotectin in adults with non bloody chronic diarrhea.

Volume 2022, Issue 10, October 2022, Pages 158-163
Mohamed AbuElmagd AbdelRahman; Mohammed Nabil rafaat; Ismail Mohamed El Mancy; Mohamed Ahmed Mustafa
16.

Combination of High Fecal Calprotectin and High Scores of The Frequency of Night Motion and Urgency Might Discriminate Ulcerative Colitis Patients with Bad Quality of Life and Fatigue in Ulcerative Colitis Patients

Volume 89, Issue 2, October 2022, Pages 7865-7872
Amira R. El-Ansary; Inas Abd El Rahim Ali; Mahmoud R. M. El-Ansary
17.

Relation between Serum and Fecal Calprotectin and Atopic Dermatitis

Volume 7, Issue 9, September 2022, Pages 47-53
A A.Ali; A M.El-refaei; S H.Ahmed; N F.alhusseini
18.

Interleukin-6 as a reliable biomarker for inflammatory bowel diseases

Volume 27, 1-2, May 2022
Islam Abd El-Hamid El-Zayyadi; Aya M. El-Noby; Yasmin N. Kamel; Sahar T. Mohamed
19.

Association between molecularly detected Entamoeba species and fecal calprotectin level among a cohort of diarrheic patients

Volume 15, Issue 1, April 2022, Pages 86-91
Salwa Morsy; Tamer Haydara; Marwa Ghallab
20.

EFFICACY OF FECAL CALPROTECTIN AS A MARKER FOR THE PATHOGENICITY OF BLASTOCYSTIS HOMINIS

Volume 51, Issue 3, December 2021, Pages 641-646
AMIRA RAAFAT; IMAN R. ABDEL-SHAFI; MOUSA A. M. ISMAIL; NOHA M. AMIN
21.

Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases

Volume 4, Issue 2, July 2021, Pages 14-24
Hasan Sedeek Mahmoud; Hanan Mahmoud Fayed; Mahmoud El Dosoky; Mohammed Tag-Adeen
22.

Fecal Calprotectin Level in Term and Preterm Babies before and after Starting of Feeding

Volume 82, Issue 4, January 2021, Pages 733-739
Mohammed Mahmoud Romih; Eman M. M. El-hindawy; Naglaa Ali Khalifaa; Ahmed Mohammed Othman
23.

Clinical characteristics versus human leukocyte antigen class-II DRB1 alleles profiles and fecal calprotectin level in Giardia lamblia-infected children

Volume 13, Issue 2, August 2020, Pages 126-134
Ayat ElBlihy; Ahmed Megahed; Raefa Atia; Fatma Auf; Samar El-Beshbishi
24.

Association of T helper type 2 cytokines with sensitization to food in pediatric atopic dermatitis patients

Volume 17, Issue 2, October 2019, Pages 69-76
Ilona Paulauskaitė; Audronė Eidukaitė; Odilija Rudzevičienė; Rasa Orentaitė
25.

Use of Fecal Calprotectin as A Predictor of Spontaneous Bacterial Peritonitis in Post Hepatitis C Cirrhotic Egyptian Patients

Volume 76, Issue 3, July 2019, Pages 3736-3740
Atef Abou Elfotouh Ibrahim; Mohammed Salah Ali Hussein; Zakarya Mohamed Zakarya Shady; Mahmoud Mohammed Mohammed Metwally; Abdelrahman Saad Mohamed Amer
First Page Previous Page 1 2 Next Page Last Page